33 Results

People

  1. Gupta
    Gupta
  2. Park
    Park
  3. Perales
    Perales
  4. Dahi
    Dahi
  5. Mailankody
    Mailankody
  6. Palomba
    Palomba
  7. Scordo
    Scordo
  8. Shah
    Shah
  9. Shouval
    Shouval
  10. Usmani
    Usmani

Groups

  1. Department of Medicine (18)
  2. Hematologic Malignancies, Division of (18)
  3. Center for Hematologic Malignancies (17)
  4. Bone Marrow Transplant (8)
  5. Department of Pathology and Laboratory Medicine (8)
  6. Adult Leukemia (7)
  7. CTCR Scholars (5)
  8. Survivorship Research (5)
  9. Biostatistics Service (4)
  10. Epidemiology and Biostatistics (4)
  1. "apheresis"
Formats
  1. Journal Article (26)
  2. Review (4)
  3. Research Letter (2)
  4. Conference Paper (1)
Groups
  1. Department of Medicine (18)
  2. Hematologic Malignancies, Division of (18)
  3. Center for Hematologic Malignancies (17)
  4. Bone Marrow Transplant (8)
  5. Department of Pathology and Laboratory Medicine (8)
  6. Adult Leukemia (7)

More Groups

People
  1. Gaurav Gupta (4)
  2. Jae Park (4)
  3. Miguel-Angel Perales (4)
  4. Sean Devlin (4)
  5. Gunjan Shah (3)
  6. Maria Palomba (3)

More People

Years
  1. 2025 (4)
  2. 2024 (7)
  3. 2023 (3)
  4. 2022 (5)
  5. 2021 (1)
  6. 2019 (2)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (4)
  2. Blood Advances (3)
  3. Transfusion (3)
  4. Haematologica (2)
  5. Journal of Clinical Oncology (2)
  6. Journal of the National Comprehensive Cancer Network (2)

More Publications

Publishers
  1. Elsevier Inc. (6)
  2. American Society of Hematology (4)
  3. Blackwell Publishing (3)
  4. American Society of Clinical Oncology (2)
  5. Biomed Central Ltd (2)
  6. Ferrata Storti Foundation (2)

More Publishers

Results (33)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells
    Journal Article

    Yankelevich, M.; Thakur, A.; Modak, S.; Chu, R.; Taub, J.; Martin, A.; Schalk, D.; Schienshang, A.; Whitaker, S.; Rea, K.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Patient blood management and its role in supporting blood supply
    Review

    Gammon, R. R.; Dubey, R.; Gupta, G. K.; Hinrichsen, C.; Jindal, A.; Lamba, D. S.; Mangwana, S.; Nair, A. R.; Nalezinski, S.; Bocquet, C.
    Journal of Blood Medicine (2023)

    Fulltext@MSK | Save
  • Current advances in 2022: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (AABB) Clinical Transfusion Medicine Committee
    Review

    Metcalf, R. A.; Cohn, C. S.; Bakhtary, S.; Gniadek, T.; Gupta, G.; Harm, S.; Haspel, R. L.; Hess, A. S.; Jacobson, J.; Lokhandwala, P. M.; more...
    Transfusion (2023)

    Fulltext@MSK | Save
  • Efficacy, safety, and cost of mobilization strategies in multiple myeloma: A prospective, observational study
    Research Letter

    Dhakal, B.; Zhang, M. J.; Burns, L. J.; Tang, X.; Meyer, C.; Mau, L. W.; Nooka, A. K.; Stadtmauer, E.; Micallef, I. N.; McGuirk, J.; more...
    Haematologica (2023)

    Fulltext@MSK | Save
  • Health-related quality of life in patients given ciltacabtagene autoleucel for relapsed or refractory multiple myeloma (CARTITUDE-1): A phase 1b–2, open-label study
    Journal Article

    Martin, T.; Lin, Y.; Agha, M.; Cohen, A. D.; Htut, M.; Stewart, A. K.; Hari, P.; Berdeja, J. G.; Usmani, S. Z.; Yeh, T. M.; more...
    The Lancet Haematology (2022)

    Fulltext@MSK | Save
  • Patterns of use, outcomes, and resource utilization among recipients of commercial axicabtagene ciloleucel and tisagenlecleucel for relapsed/refractory aggressive B cell lymphomas
    Journal Article

    Riedell, P. A.; Hwang, W. T.; Nastoupil, L. J.; Pennisi, M.; McGuirk, J. P.; Maziarz, R. T.; Bachanova, V.; Oluwole, O. O.; Brower, J.; Flores, O. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Considerations for immune effector cell therapy collections: A white paper from the American Society for Apheresis
    Journal Article

    Liu, H. D.; Su, L.; Winters, J. L.; Thibodeaux, S. R.; Park, Y. A.; Wu, Y.; Schwartz, J.; Zubair, A. C.; Schneiderman, J.; Gupta, G. K.; more...
    Cytotherapy (2022)

    Fulltext@MSK | Save
  • Current advances in transfusion medicine 2021: A critical review of selected topics by the AABB Clinical Transfusion Medicine Committee
    Review

    Metcalf, R. A.; Cohn, C. S.; Allen, E. S.; Bakhtary, S.; Gniadek, T.; Gupta, G.; Harm, S.; Haspel, R.; Hess, A.; Jacobson, J.; more...
    Transfusion (2022)

    Fulltext@MSK | Save
  • Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: A noncomparative cohort analysis
    Journal Article

    Hamadani, M.; Gopal, A. K.; Pasquini, M.; Kim, S.; Qiu, X.; Ahmed, S.; Lazaryan, A.; Raj Bhatt, V.; Daly, A.; Lulla, P.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Brentuximab vedotin in combination with nivolumab in relapsed or refractory Hodgkin lymphoma: 3-year study results
    Journal Article

    Advani, R. H.; Moskowitz, A. J.; Bartlett, N. L.; Vose, J. M.; Ramchandren, R.; Feldman, T. A.; LaCasce, A. S.; Christian, B. A.; Ansell, S. M.; Moskowitz, C. H.; more...
    Blood (2021)

    Fulltext@MSK | Save